Inventor · disambiguated record
Ulrich Bothe
Also filed as: BOTHE ULRICH
23 granted patents·13 pending applications·86 citations·filing 2003–2022
93Inventor score
Top patents by PatentIndex Score
36 records- 0195US10308634B2Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said new substituted indazoles, and use of said new substituted indazoles to produce drugsBayer Pharma AG·Filed 2015·Granted Jun 4, 2019·17 cites·27 claims
- 0292US10793545B2Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said new substituted indazoles, and use of said new substituted indazoles to produce drugsBayer Pharma AG·Filed 2019·Granted Oct 6, 2020·7 cites·27 claims
- 0390US12006303B2Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said substituted indazoles, and use of said substituted indazoles to produce drugsBayer Pharma AG·Filed 2022·Granted Jun 11, 2024·1 cites·24 claims
- 0490US12006304B2Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said substituted indazoles, and use of said substituted indazoles to produce drugsBayer Pharma AG·Filed 2022·Granted Jun 11, 2024·1 cites·9 claims
- 0590US9951086B2Indazolecarboxamides, processes for their preparation, pharmaceutical preparations comprising them and their use for producing medicamentsBayer Pharma AG·Filed 2014·Granted Apr 24, 2018·21 cites·19 claims
- 0685US10435396B22-substituted indazoles, methods for producing same, pharmaceutical preparations that contain same, and use of same to produce drugsBayer Pharma AG·Filed 2017·Granted Oct 8, 2019·7 cites·8 claims
- 0783US8148411B22-hetarylthiazole-4-carboxamide derivatives, their preparation and use as pharmaceuticalsBOTHE ULRICH·Filed 2008·Granted Apr 3, 2012·9 cites·6 claims
- 0881US7825128B2Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugsBAYER SCHERING PHARMA AG·Filed 2006·Granted Nov 2, 2010·7 cites·18 claims
- 0974US7427610B22-substituted estra-1,3,5(10)-triene-3-yl sulfamate with an anti-tumour actionSTERIX LTD·Filed 2004·Granted Sep 23, 2008·8 cites·21 claims
- 1073US7897626B22-substituted thiazole-4-carboxamide derivatives, their preparation and use as pharmaceuticalsBAYER SCHERING PHARMA AG·Filed 2008·Granted Mar 1, 2011·2 cites·10 claims
- 1172US8163739B22-arylthiazole-4-carboxamide derivatives, their preparation and use as pharmaceuticalsBOTHE ULRICH·Filed 2008·Granted Apr 24, 2012·2 cites·2 claims
- 1271US8642611B2Alkynylpyrimidines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of sameHARTUNG INGO·Filed 2008·Granted Feb 4, 2014·2 cites·15 claims
- 1370US11992481B2Use of 2-substituted indazoles for the treatment and prophylaxis of autoimmune diseasesBayer Pharma AG·Filed 2022·Granted May 28, 2024·0 cites·12 claims
- 1470US2021053941A1Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said new substituted indazoles, and use of said new substituted indazoles to produce drugsBayer Pharma AG·Filed 2020·Application pending·0 cites
- 1569US7419972B22-substituted estra-1,3,5(10)-trien-17-ones as inhibitors of 17β-hydroxy steroid dehydrogenase type 1SCHERING AG·Filed 2005·Granted Sep 2, 2008·2 cites·26 claims
- 1669US2022241261A1Combinations of inhibitors of irak4 with inhibitors of btkBayer Pharma AG·Filed 2021·Application pending·0 cites
- 1767US12459916B2Substituted indazoles useful for treatment and prevention of allergic and/or inflammatory diseases in animalsBayer Pharma AG·Filed 2022·Granted Nov 4, 2025·0 cites·22 claims
- 1867US2019388410A1Combinations of inhibitors of irak4 with inhibitors of btkBayer Pharma AG·Filed 2019·Application pending·0 cites
- 1957US2018289685A1Combinations of inhibitors of irak4 with inhibitors of btkBayer Pharma AG·Filed 2016·Application pending·0 cites
- 2055US8492570B22-substituted estra-1,3,5(10)-triene-3-yl sulfamate with an anti-tumor actionHILLISCH ALEXANDER·Filed 2008·Granted Jul 23, 2013·0 cites·5 claims
- 2155US2021085664A1Use of 2-substituted indazoles for the treatment and prophylaxis of autoimmune diseasesBayer Pharma AG·Filed 2020·Application pending·0 cites
- 2252US7250408B2Glucocorticoid receptor antagonists for prophylaxis and therapy of glucocorticoid-mediated hypogonadism, of sexual dysfunction and/or infertilityBAYER SCHERING PHARMA AG·Filed 2003·Granted Jul 31, 2007·0 cites·10 claims
- 2348US2023113037A1[1,2,4]triazolo[1,5-c]quinazolin-5-aminesBAYER AG·Filed 2020·Application pending·0 cites
- 2447US7199115B217α-fluorosteroids, pharmaceutical compositions containing 17α-fluorosteroids and a method of making themSCHERING AG·Filed 2005·Granted Apr 3, 2007·0 cites·8 claims
- 2546US10730856B2Benzimidazole derivatives as EP4 ligandsBayer Pharma AG·Filed 2014·Granted Aug 4, 2020·0 cites·9 claims
- 2646US2019125736A1Use of 2-substituted indazoles for the treatment and prophylaxis of autoimmune diseasesBayer Pharma AG·Filed 2017·Application pending·0 cites
- 2746US2020216413A1Substituted indazoles useful for treatment and prevention of allergic and/or inflammatory diseases in animalsBAYER ANIMAL HEALTH GMBH·Filed 2017·Application pending·0 cites
- 2844US7408060B2Nonsteroidal progesterone receptor modulatorsSCHERING AG·Filed 2006·Granted Aug 5, 2008·0 cites·26 claims
- 2943US2007010514A1Non-steroidal progesterone receptor modulatorsBOTHE ULRICH·Filed 2006·Application pending·0 cites
- 3040US9714266B2Estra-1,3,5(10),16-tetraene-3-carboxamides for inhibition of 17.beta.-hydroxysteroid dehydrogenase (AKR1C3)Bayer Pharma AG·Filed 2014·Granted Jul 25, 2017·0 cites·10 claims
- 3140US2015080438A16,7-Dihydro-5H-benzo[7]annulene derivatives, processes for their preparation, pharmaceutical products comprising them and their use for preparing medicamentsBAYER IP GMBH·Filed 2012·Application pending·0 cites
- 3239US9512169B23-substituted estra-1,3,5(10),16-tetraene derivatives, methods for the production thereof, pharmaceutical preparations containing same, and use thereof for the production of medicamentsBayer Pharma AG·Filed 2013·Granted Dec 6, 2016·0 cites·10 claims
- 3339US2007197524A1Fluorenes and carbazoles as ligands of the EP2 receptorBRAUER NICO·Filed 2006·Application pending·0 cites
- 3436US9487554B2Estra-1,3,5(10),16-tetraene-3-carboxamide derivatives, processes for their preparation, pharmaceutical preparations comprising them and their use for preparing medicamentsBAYER IP GMBH·Filed 2012·Granted Nov 8, 2016·0 cites·8 claims
- 3536US2013252890A16,7-dihydro-5h-benzo[7]annulene derivatives, process for preparation thereof, pharmaceutical preparations comprising them, and the use thereof for production of medicamentsWINTERMANTEL TIM·Filed 2011·Application pending·0 cites
- 3634US2017260226A13-nitrogen or sulphur substituted oestra-1,3,5(10),16-tetraene akr1c3 inhibitorsBayer Pharma AG·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ulrich Bothe files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →